| |
|
| |
| |
| Milestones - India |
|
| (Year 2000 onwards) |
2009 |
| |
| Syngenta India on high growth mode, crosses Rs. 1400 Cr. turnover |
| March , 2009 |
| |
| Company records growth on various parameters – new products, new markets, new initiatives, more recognition |
| March , 2009 |
| |
|
2008 |
| |
| Received EIA approval, TMX expansion plan gets required boost, facility progressing as planned |
| Octomber , 2008 |
| |
| Syngenta refreshed brand launched internally, leveraging external market strengths |
| April , 2008 |
| |
| Syngenta India crosses the landmark Rs. 1000 Cr. Turnover, enters top 12 countries, within Syngenta |
| March , 2008 |
| |
| Further expansion of TMX plant initiated, seeking Environ Impact Assessment (EIA) approval from government & surrounding communities |
| February , 2008 |
| |
|
2007 |
| |
| Thiamethoxam exports increased dramatically, from 200 mio. To 3000 mio, on global demand |
| December , 2007 |
| |
| Amistar, another star molecule, launched in India, within six months of global launch, excellent response from F&V growers |
| August , 2007 |
| |
| Syngenta shares were de-listed from Mumbai stock exchange following successful open offer by Syngenta |
| June , 2007 |
| |
| Actara, the first product of the new chemistry, Neonecotine, launched. Welcomed by the progressive growers |
| April , 2007 |
| |
| Capital investment of US$ 150 (check) mio for seed processing units at three locations, boosting the already buoyant seeds business |
| April , 2007 |
| |
| Set up Thiamethoxam manufacturing facility in Goa, for global requirements |
| April , 2007 |
| |
|
2006 |
| |
| Global R & T center inaugurated at Goa. The only Chemistry Research Facility outside Europe for Syngenta. Also the only KILO Lab for Syngenta in the World |
| November , 2006 |
| |
|
2005 |
| |
| Syngenta Board approves formation of Syngenta Foundation India, the CSR arm |
| April , 2005 |
| |
| Successful restructuring of businesses – SBU structures formed in Crop Protection –company on growth path |
| February , 2005 |
| |
|
2004 |
| |
| Goa manufacturing site became a strategic Manufacturing GLOBAL sourcing base |
| January , 2004 |
| |
|
2003 |
| |
| Post successful merger, company decides to realign business units, business consolidation planned |
| April , 2003 |
| |
| First buyback offer to Indian shareholders. Syngentastake increased from 51% to 84% |
| March , 2003 |
| |
|
2002 |
| |
| Syngenta, in its pursuit for offering only the best chemistries to the growers, discontinued manufacturing of the fast selling Dimecron (Phosphamidon) and Nuvacron (Monocrotofos), |
| April , 2002 |
| |
|
2001 |
| |
| First AGM, as a listed company, was held. First dividend offered was 20% |
| September , 2001 |
| |
| The consolidation of the agri-business showed good market acceptance, sales on upswing |
| April , 2001 |
| |
|
2000 |
| |
Syngenta India was listed on Mumbai stock exchange. First Board Meeting was held when major appointments were announced |
| Nov.mber , 2000 |
| |
| Syngenta AG was formed by merging of the agri-businesses of Novartis & Astra Zeneca |
| April , 2000 |
| |
|
|
|
| |
Top |
|
|